| MAGELLAN Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients | |
Alexander T. Cohen, MD, Bayer HealthCare AG, Leverkusen, Germany |
|
Registration & Housing
- Scientific Sessions Registration Rates
- Group Registration and Housing
- Exhibitor Registration and Housing
- International Travel Tips
- Transportation
- Hotel List and Map
- Terms and Conditions
- Industry News Room Registration
Programming
- ReSuscitation Science Symposium
- Submit Science
- 26 Programming Tracks
- Late-Breaking
- Cardiovascular Nursing Clinical Symposium
- Final Program (Scientific Sessions)
- Continuing Education
- Case Theaters: Learning at the Movies
- 7 Cardiovascular Cores
Science & Technology Hall (Exhibits)
- Exhibiting Opportunities
- Scientific Sessions Promotional Opportunities
- Exhibit Hall Map
- Unofficial Satellite Events (USE's)
- USE Promotional Opportunities
- USE Rules, Regulations, Guidelines
